ArticleFrontiers in immunology2023

Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China.

Maosheng Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.